Vaccine composition
US7344720B2 · kind B2 · utility
7Cited by
1References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 15, 2004 |
| Grant date | Mar 18, 2008 |
| Priority date | — |
| Expiry date | Dec 29, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a pharmaceutical composition comprising at least one vaccine antigen, which also comprises at least one phosphoric ester derivative of phosphatidylcholine having the structure:in which:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.